I am a healthcare professional
If you are a healthcare professional looking to find out more about heavy menstrual bleeding and contraception, please click below.
If you are not a healthcare professional and you want to learn about contraception please click below.
If you are not a healthcare professional and you want to learn about heavy menstural bleedingplease click below.
HCP

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

Bayer logo

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

Qlaira (Estradiol Valerate/dienogest) what you need to know

This promotional meeting is part of the Women’s Health Matters Educational Programme that is organised and fully funded by Bayer

Jun 22 2020 | 17:56 - 17:56

Recorded: Jun 22 2020 | 17:56 - 17:56

Duration Time: 15 Minutes

The on-demand educational will cover:

  • Qlaira is an oral combined hormonal contraceptive with a license for heavy menstrual bleeding
  • Qlaira is subject to the same prescribing recommendations (UKMEC) as any other CHC
  • Qlaira's bleeding profile may be helpful to women in bridging contraception, who are unable to access or desire a 52mg levonorgestrel containing IUS.

Speakers

Pic

Dr Jane Davis

GP with a special interest in women’s health

NHS South West

Jane is a GP with a special interest in women’s health whose current roles include Coil trainer, Clinical Skills Tutor, University of Plymouth & Speciality Dr for Brook Young People, Cornwall. Appearing on TV, as the public face of the PCWHF “Rock my Menopause” campaign. A feminist writer and medical educationalist.

eventform

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk. Adverse events should also be reported to Bayer plc Tel: 01182063500, Fax: 01182063703, Email: pvuk@bayer.com.


If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: qualitycomplaints@bayer.com For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.

  • PP-PF-WHC-GB-0392 August 2020

Copyright © 2019,
Bayer plc

This website is intended for UK healthcare professionals only. Women’s Health Matters is organised and funded by Bayer and contains promotional content.

Prescribing Information (PI) can be found via the links below:
Mirena® (52 mg intrauterine delivery system Levonorgestrel)
Kyleena® (19.5 mg intrauterine delivery system Levonorgestrel)
Jaydess® (13.5 mg intrauterine delivery system Levonorgestrel)
Qlaira® (estradiol valerate/dienogest)
Microgynon® (levonorgestrel/ethinylestradiol)

Page last modified Fri, 08/21/2020 - 13:05

Bayer logo